Considerations for ethics review of big data health research: A scoping review by Ienca, Marcello et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Considerations for ethics review of big data health research: A scoping
review
Ienca, Marcello; Ferretti, Agata; Hurst, Samia; Puhan, Milo; Lovis, Christian; Vayena, Effy
Abstract: Big data trends in biomedical and health research enable large-scale and multi-dimensional
aggregation and analysis of heterogeneous data sources, which could ultimately result in preventive, di-
agnostic and therapeutic benefit. The methodological novelty and computational complexity of big data
health research raises novel challenges for ethics review. In this study, we conducted a scoping review
of the literature using five databases to identify and map the major challenges of health-related big data
for Ethics Review Committees (ERCs) or analogous institutional review boards. A total of 1093 publica-
tions were initially identified, 263 of which were included in the final synthesis after abstract and full-text
screening performed independently by two researchers. Both a descriptive numerical summary and a
thematic analysis were performed on the full-texts of all articles included in the synthesis. Our find-
ings suggest that while big data trends in biomedicine hold the potential for advancing clinical research,
improving prevention and optimizing healthcare delivery, yet several epistemic, scientific and normative
challenges need careful consideration. These challenges have relevance for both the composition of ERCs
and the evaluation criteria that should be employed by ERC members when assessing the methodological
and ethical viability of health-related big data studies. Based on this analysis, we provide some prelim-
inary recommendations on how ERCs could adaptively respond to those challenges. This exploration is
designed to synthesize useful information for researchers, ERCs and relevant institutional bodies involved
in the conduction and/or assessment of health-related big data research.
DOI: https://doi.org/10.1371/journal.pone.0204937
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-165262
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Ienca, Marcello; Ferretti, Agata; Hurst, Samia; Puhan, Milo; Lovis, Christian; Vayena, Effy (2018). Con-
siderations for ethics review of big data health research: A scoping review. PLoS ONE, 13(10):e0204937.
DOI: https://doi.org/10.1371/journal.pone.0204937
RESEARCH ARTICLE
Considerations for ethics review of big data
health research: A scoping review
Marcello Ienca1☯, Agata Ferretti1☯, Samia Hurst2, Milo Puhan3, Christian Lovis4,
Effy VayenaID1*
1 Health Ethics and Policy Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich,
Switzerland, 2 Institute for Ethics, History and the Humanities, Faculty of Medicine, University of Geneva,
Geneva, Switzerland, 3 Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich,
Switzerland, 4 Division of Medical Information Sciences, Department of Radiology and Medical Informatics,
University Hospital of Geneva, Geneva, Switzerland
☯ These authors contributed equally to this work.
* effy.vayena@hest.ethz.ch
Abstract
Big data trends in biomedical and health research enable large-scale and multi-dimensional
aggregation and analysis of heterogeneous data sources, which could ultimately result in
preventive, diagnostic and therapeutic benefit. The methodological novelty and computa-
tional complexity of big data health research raises novel challenges for ethics review. In
this study, we conducted a scoping review of the literature using five databases to identify
and map the major challenges of health-related big data for Ethics Review Committees
(ERCs) or analogous institutional review boards. A total of 1093 publications were initially
identified, 263 of which were included in the final synthesis after abstract and full-text
screening performed independently by two researchers. Both a descriptive numerical sum-
mary and a thematic analysis were performed on the full-texts of all articles included in the
synthesis. Our findings suggest that while big data trends in biomedicine hold the potential
for advancing clinical research, improving prevention and optimizing healthcare delivery, yet
several epistemic, scientific and normative challenges need careful consideration. These
challenges have relevance for both the composition of ERCs and the evaluation criteria that
should be employed by ERC members when assessing the methodological and ethical via-
bility of health-related big data studies. Based on this analysis, we provide some preliminary
recommendations on how ERCs could adaptively respond to those challenges. This explo-
ration is designed to synthesize useful information for researchers, ERCs and relevant insti-
tutional bodies involved in the conduction and/or assessment of health-related big data
research.
Introduction
The generation of digital data has drastically increased in the last years due to the ubiquitous
deployment of digital technology as well as advanced computational analytics techniques [1,
2]. The term big data is still vaguely defined. In general terms, big data involves large sets of
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data with diverse levels of analysable structuration, coming from heterogeneous sources
(online data, social media profiles, financial records, self-tracked parameters, etc.), produced
with high frequency and which can be further processed and analysed using computational
techniques. While the term big data has become nearly ubiquitous, there is controversy over
what data volumes are sufficiently large to obtain the big data label. Dumbill, for example, sug-
gested that data should be considered big when they cross the threshold of the conventional
databases systems’ capacity in processing information [3].
Big data trends characterize various sectors including basic science [1, 4], business [5], gov-
ernment [6], national security [7] and transportation [8]. Big data trends have increasingly
pervaded also the healthcare domain, as new health-related data sources have grown in volume
and variety, and became available for large-scale aggregation and high-speed analysis [9].
These include Electronic Health Records (EHRs), data from mobile health (mHealth) applica-
tions, medical blogs and web-networks [10] [11], healthcare robotics [12], medical internet of
things [13], as well as direct-to-consumer genetic [14], and screening tests [15]. Additionally,
health-related information can be derived not only from digital health applications, but also
from non-strictly-medical data sources [16] such as online personal dietary programs, fitness
club memberships and Twitter hashtags [17]. Health-related big data is the umbrella term
used to describe extremely large and heterogeneous data sets that may be analysed computa-
tionally to reveal patterns, trends, and correlations, that have relevance for human health [18].
The availability of health-related big data holds the promise of exerting a positive impact on
biomedical research. For example, tailoring diagnostics to automated analyses of high resolu-
tion images has become a standard procedure in cancer research [19]. In parallel, mapping
and collecting large-scale data volumes enables the creation of epidemiological models that
can inform about an epidemics’ space-time propagation. Finally, novel and patient-tailored
therapeutic opportunities might emerge from the possibility of continuously monitoring
patient health, tracking pathologic characteristics at specific points in time, and aggregating
heterogeneous data sources [20]. These benefits might occur both in public health and at the
individual level. Bates [21] argued that the use of big data has a valuable impact on public
health, since it might help identify and promptly intervene on high-risk and high-cost
patients.
While opening the prospect of clinical benefit, the use of health-related big data raises impor-
tant challenges. In light of their methodological novelty, potentially far-reaching impacts, and
computational complexity, big data approaches to human health have been claimed to raise eth-
ical, legal and social implications [22]. Ethical and legal challenges include the risk to compro-
mise privacy, personal autonomy, and the solidarity-based approach to healthcare funding, as
well as effects on public demand for transparency, trust, and fairness while using big data [23].
Furthermore, authors have listed data heterogeneity, data protection, analytical flows in analys-
ing data, and the lack of appropriate infrastructures for data storage as critical technical and
infrastructural issues that might endanger a big-data-driven healthcare [24]. While some of
these challenges have received scientific and institutional attention, other ones have remained
largely unexplored. In 2016, a review identified a number of areas of concern associated with
health-related big data that did not obtained adequate attention among researchers [22]. These
included group-level ethical harms, the intimate link between epistemological and ethical issues,
the distinction between harms to data subject resulting from, respectively, academic and com-
mercial uses of big data, the problematic fiduciary relationship between data custodian and data
subjects, the role of data ownership and intellectual property as a mechanism for data control,
and, finally, the provision of data access rights to data subjects.
The ethical, legal and social implications of health-related big data raise novel challenges
also for Ethics Review Committees (ERCs). ERCs and institutional review boards are
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increasingly requested to evaluate an ever-growing number of research projects and associated
activities involving big data (large data volumes and big data analytics), whose risks and bene-
fits often appear hard to assess. Some authors have called for the development of comprehen-
sive regulatory policies for healthcare entities and new computing safeguards that can address
public concerns, such as the protection of individually identifiable information [25]. However,
in absence of specific guidelines and comprehensive evaluation studies, ERCs might be facing
uncertainty on how to review health-related big data projects and according to which evalua-
tive criteria. In fact, researchers have observed that traditional conceptual tools and/or legal
requirements for ethics review in clinical research like informed consent, minimal risk and fair
subject selection might be of limited help, if not ill suited, for the evaluation of big data projects
[26, 27]. The reason for that stems from the fact that these tools were conceived in the context
of conventional clinical research (e.g. clinical trials) not in connection to the evolving applica-
tions and innovative research designs of big data research [27]. For example, informed consent
is often not practical to obtain for studies involving a retrospective access to data from millions
of individuals.
The nature of big data studies also challenges the current mandate and purview of ERCs.
For example, studies involving publicly available and anonymized data have traditionally
been perceived to be outside of the purview of ERCs. This would include data from Twitter
(which are public by default), Facebook or other online platforms. Furthermore, ethical safe-
guards for human subjects research “are often written with definitions that exclude Internet
research”[28]. This is problematic for a twofold reason. First, research has shown that big data
analytics can reveal sensitive information from seemingly innocuous public data points,
including information that the original data generators might reasonably wish to keep private.
For example, a recent study has successfully used deep neural networks to predict the sexual
orientation of users based on facial images from public profiles posted on dating website [29].
Second, several studies have shown that de-identified [30] and even anonymized data [31] can
be reverse engineered to re-identify individuals, leading experts to the conclusion that “there is
no such thing as anonymous data”. This raises the question of whether big data projects should
require oversight by an ERC even when the data collected are public and anonymized or de-
identified. A recent systematic review has concluded that most normative documents deem
the review of an ERC as necessary to address the concerns associated with the use of anon-
ymized data for research [32]. In contrast, when ERCs waived the review of big data studies
involving publicly available and anonymized data repositories because they considered them
outside their purview, such as in the case of Facebook’s “emotional contagion” study [33],
experts criticized this narrow interpretation of the ERC’s mandate [34].
In the present study, we aim to identify the promises and challenges of health-related big
data research that have relevance for ERCs. Furthermore, we use these findings to suggest how
ERCs could adaptively respond to this methodological transformation. This exploration is
designed to synthesize useful information for researchers, ERCs and relevant institutional bod-
ies involved in the conduction and/or assessment of health-related big data research.
Methods
On the 18thof September 2018 we conducted a scoping review of the scientific literature and
searched five databases (EMBASE, Web of Science, Pubmed, IEEE Xplore, and Scopus) to
retrieve eligible publications. We searched title, abstract, and keywords for the terms: ("big
data" OR “Artificial Intelligence” OR "data science" OR "digital data") AND (“medical” OR
“healthcare” OR “clinical” OR "personalised medicine") AND (“policy” OR “ethics” OR “gov-
ernance” OR "ethics committee" OR “IRB” OR "review board" OR “assessment”). Query logic
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was modified to adapt to the language used by each engine or database. Screening identified
1093 entries. All entries were imported into the Endnote literature manager software. Three
phases of filtering were performed independently by two researchers to minimize subjective
bias.
The scoping review is a review method aimed at synthesizing research evidence and map-
ping the existing literature in a certain field of interest [35]. Unlike a systematic review, scoping
review methods are considered of particular use when the topic has not yet been extensively
reviewed or is of a complex or heterogeneous nature [35, 36]. Following the recommendations
by Pham et al. [36], the study selection process was conducted and presented using the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses (http://prisma-statement.
org/) as a guide (see Fig 1).
First, duplicates were removed both automatically using the Endnote tool for duplicate
detection and manually based on abstract screening. A total of 226 articles was removed at this
stage.
Second, eligibility assessment was performed independently by two of the co-authors on
the remaining 867 articles through title-abstract screening and, subsequently, full text screen-
ing. Diverging inclusion choices between the two reviewers were discussed with the research
group with documented reasons. Studies included in the synthesis had the following features:
(i) original articles, book chapters or conference proceedings; (ii) written in English, Italian,
French or German (languages spoken by the researchers); (iii) published before September
Fig 1. Scoping literature review flow chart (PRISMA).
https://doi.org/10.1371/journal.pone.0204937.g001
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18th, 2017; and (iv) focused on the assessment of big data trends in the biomedical/healthcare
context. Reviews, letters to the editors, business reports and dissertations were not included. A
total of 263 studies were included in the final synthesis and imported manually into Microsoft
Excel 15.40 format based on a shared data-charting form. Following the recommendations to
enhance scoping study methodology delineated by Levac et al. [37], the data-charting form
was collectively developed by our research team to determine which variables to extract from
the review data.
Third, based on the same recommendations, we performed both a descriptive numerical
summary and a thematic analysis. In the former analysis, both relative and cumulative fre-
quencies were extracted and graphically represented using bar charts. Following Arksey and
O’Malley [36], our descriptive numerical summary also included the total number of articles
included, types of study design (empirical vs. non empirical), years of publication etc. In the
latter analysis, recurrent thematic patterns were identified through full-text screening and sub-
sequent coding. The coding phases was independently performed by two researchers. Once
conceptually stable thematic patterns emerged from the codes, these were grouped together
into a system of themes and subthemes. All entries were checked anew through an automated
text search for the presence of the emerging themes. Following Braun and Clarke [38], codes
that did not seem to fit into any main theme, were temporarily housed in a “miscellaneous”
group and subsequently either clustered into a new theme or reallocated to an existing the-
matic group after consultation. Internal consultation was performed among all members of
our research team to integrate and validate our findings.
Results
Our results reveal a large, diverse and rapidly growing body of literature on the impact of big
data in the biomedical domain. Data show that the overall number of articles published in the
time period 2012–2017 is 131 times higher compared to the period 2001–2005 as represented
in Fig 2.
Data breakdown by medical speciality and field of medical application indicates that big
data approaches have been discussed and evaluated in relation to several branches of medicine
including neurology and psychiatry (n = 31), oncology (n = 17), cardiology (n = 8), medical
Fig 2. Increase over time in research papers discussing the challenges of health-related big data. N.B. The search
was performed on September 18, 2017. Therefore, the full number of articles for year 2017 was calculated by projecting
the data until September 18.
https://doi.org/10.1371/journal.pone.0204937.g002
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genetics (n = 8), immunology and infectious diseases (n = 8), as well as nuclear medicine and
radiology (n = 6). Crossfield evaluations of health-related big data appeared highly prevalent
(n = 155).
Thematic analysis identified a number of potential opportunities and challenges associated
with health-related big data approaches, many of which have relevance for ethics review.
Opportunities could be grouped into four main themes: biomedical research, prevention,
healthcare delivery and healthcare management. Potential benefits in the research domain
include the possibility of collecting real-world data, accelerating the development of new medi-
cal technology and facilitating translational research. Big data was also associated with the
improvement of preventive measures at both the individual and population level. In relation to
care delivery, the following benefits were envisioned: precision and personalized medicine,
earlier and more accurate diagnostics, enhanced clinical decision-making, ubiquitous health
monitoring, improved patient safety and better therapy. Subsequent numeric analysis of the-
matic clusters is presented in Table 1.
Envisioned challenges appeared of seven major types: technical (n = 125), ethical (n = 81),
methodological (n = 66), regulatory (n = 39), social (n = 16), infrastructural (n = 11) and finan-
cial (n = 10). Technical challenges relate to issues inherent in the data ecosystem. These include
data security, data quality, data storage, data linkage, and tools for data reuse. Methodological
challenges relate to the system of methods used in the study and include issues of standardizing
data and metadata, integrating and processing data, monitoring resource utilisation and com-
pensating for incomplete data. Regulatory challenges relate to rules or directives such as those
regulating data ownership and the accountability of actors in relation to the potential risks
associated with using and managing data. Social challenges are those that have relevance for
human society and its members. These include, among others, secondary uses of data in rela-
tion to participants consent, sociocultural and ethnic bias and subsequent risk of discrimina-
tion, power asymmetries between data subjects and data controllers. Finally, financial and
infrastructural issues included the financial viability of data storage sites and to the level of pre-
paredness of existing infrastructures respectively.
Ethical challenges are those related to moral principles. Our analysis revealed privacy and
confidentiality to be by far the dominant concern (n = 146) in the ethical domain, followed by
informed consent (n = 49), fairness and justice (n = 34), trust (n = 23), data ownership
(n = 18) and others. Fig 3 presents a full overview of ethical considerations associated with
health-related big data studies with associated relative frequencies.
While the analysis revealed a number of implications with relevance for ethics review, only
13% of reviewed studies provided specific normative recommendations for ERCs or other
Table 1. Recurrent promises and challenges associated with health related big data that have relevance for ethics
review.
Opportunities Challenges
Healthcare Delivery (n = 276) Technical (n = 125)
Healthcare Management (n = 90) Ethical (n = 81)
Biomedical Research (n = 85) Methodological (n = 66)
Prevention (n = 45) Regulatory (n = 39)
Social (n = 16)
Infrastructural (n = 11)
Financial (n = 10)
N.B. The same study might describe >1 promise or challenge.
https://doi.org/10.1371/journal.pone.0204937.t001
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institutional review boards. Data breakdown by study methodology revealed that only a small
portion of those recommendations (n = 5; 14%) was informed by empirical methods.
A subsequent analysis of thematic co-occurrences shows a strong mutual relationship
between different thematic families, especially between technical and ethical issues, as shown
in Fig 4. In particular, technical issues such as data security and data linkage were often pre-
sented in coordination with ethical issues such as personal privacy.
Limitations
This study presents four main limitations. First, a selection bias might be present since the
search retrieved only articles written in languages known by the researchers (English, French,
German and Italian), excluding articles written in other languages. A similar limitation affects
database selection as searching other databases may have possibly identified additional rele-
vant studies. While this risk of selection bias applies to any review since the number of data-
bases that can be feasibly searched is always finite, we attempted to minimize selection bias by
exploring both domain-general and domain-specific databases, including the major databases
in biomedical research and computer science, which represent the primary interdisciplinary
intersection when it comes to biomedical big data. Second, as it was often observed in relation
Fig 3. Frequency of ethical considerations associated with health-related big data studies.
https://doi.org/10.1371/journal.pone.0204937.g003
Considerations for ethics review of big data health research: A scoping review
PLOS ONE | https://doi.org/10.1371/journal.pone.0204937 October 11, 2018 7 / 15
to scoping reviews, the explorative nature and broad focus of our search methodology makes it
‘unrealistic to retrieve and screen all the relevant literature’ [39]. However, one advantage of
the scoping methodology is the opportunity to explore also the grey literature and the second-
ary sources (e.g. bibliographies of retrieved papers), which is likely to increase comprehensive-
ness. The breadth of the research focus might have inevitably affected the depth of the analysis.
The reason for that stems from the fact that the outcomes of a scoping review, compared to
systematic review methods, are “more narrative in nature” [40] and usually not presented
through descriptive statistical analysis. Finally, our review included very heterogeneous studies
and did not assess the study quality. The reason for that stems from the fact that our main goal
was to explore the entire range of challenges that have relevance for ERCs, regardless of how
those challenges were originally addressed and discussed. While these four limitations might
prevent generalization, we believe that the scoping methodology was best suited to reflect the
explorative nature and broad focus of our research question. In fact, it has often been noted,
that scoping reviews are not intended to be exhaustive [41, 42] or to provide detailed statistical
analyses [40] but to map an heterogeneous body of literature related to a broad and novel topic
[35]. As scoping reviews are usually considered a “richly informed starting point for further
investigations” [40], future studies should consider this work as a preliminary step to a system-
atic review and associated statistical data analysis. Furthermore, they could use this general
mapping of the health-related big data topic to generate empirically testable research
hypotheses.
Discussion
The drastic increase over the past 5 years in the number of studies discussing the implications
of health-related big data confirms the research community’s increasing attention to the
Fig 4. Alluvial diagram of mutual interrelations between different thematic families (figure credit Joanna Sleigh).
https://doi.org/10.1371/journal.pone.0204937.g004
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applicability of big data approaches into the healthcare domain. As the application of big data
in healthcare [43] and the market size forecasts for big data hardware, software and profes-
sional services investments in the healthcare and pharmaceutical industry are growing steadily
[44], there will be a parallel need to assess the impact of this expanding sociotechnical trend.
This expansion can be seen as a sign of what has been defined the “inevitable application of big
data to healthcare”[10] induced by the widespread uptake of electronic health records (EHRs),
and the large-scale storing and sharing of genomic, proteomics, imaging and many other bio-
medical data.
The large prevalence of cross-field evaluations of health-related big data is an indicator of
the potential of big data approaches to aggregate data from multiple medical data sources (e.g.
combining data about gene expression and brain function in neurogenic studies) and multiple
levels of clinical intervention (e.g. linking prevention and diagnostics to therapy and care
delivery). In addition, analyses show that clinical outcomes can be produced from novel and
non-strictly medical data sources. These include using Twitter to track and even forecast dis-
ease activity [45], exploiting Facebook data for suicide prevention [46], or using seasonal pol-
len forecast to predict asthma [47, 48]. On the long term, this meta-specialty nature of big data
approaches is likely to blur traditional separations between different medical specialties and
levels of clinical intervention, opening more interfaces for inter-specialty exchange in the
healthcare and biomedical research domains. This will raise the challenge for ERCs to review
big data projects without relying on traditional discrete taxonomies of medical specialization
and/or models of clinical application. In parallel, our findings illustrate the potential applica-
bility of big data approaches to an increased variety of medical specialties. While branches of
medicine like oncology [49, 50], radiology [51] and clinical genetics [52] were already known
to be particularly suitable for big data approaches, our review revealed a promising outlook
associated with using big data in several other medical domains including neurology [53, 54],
psychiatry [55], immunology [56], nephrology [57], and geriatrics [58].
The high frequency of technical challenges addressed when assessing health-related big
data highlights the persistence of a number of technical weaknesses and limitations, most of
which are likely dependent on the historical novelty of such sociotechnical trend. These
include problems of data quality, integrity, and security. Developing robust technical solutions
that can guarantee the quality, integrity and security of the data, and allow their secure trans-
mission, linkage and storage, was often presented as a priority for any successful deployment
of big data for human health. This might require the development of better security-protecting
infrastructures, data wrangling and scripting (e.g. batch processing) tools for data cleansing in
order to guarantee the quality of data -for example, through automatic detection and removal
of corrupt or inaccurate records- as well as techniques that can preserve the integrity of data
through the entire data cycle, prevent corruption and enable interoperability. Furthermore,
distributed ledger technology, distributed storage and incremental analytics are also believed
to hold promises in the health domain [59, 60]. From the perspective of ERCs, this implies a
more rigorous yet systemic oversight [61] of technical considerations to guarantee that the
afore listed safeguards are implemented by the researchers.
The relative frequency of methodological issues, however, highlights that fixing technical
problems alone might not be sufficient to use big data for good. ERCs are usually required to
evaluate the methodological soundness of a study if this has ethical consequences. For exam-
ple, if a RCT is designed without giving participants an equal chance of being assigned to any
group, ERCs are entitled to assess the methodological soundness of the study to preserve the
principle of fairness. For the same reason, in the context of big data research, ERCs might be
entitled to assess the soundness of studies whose methods may result in algorithmic discrimi-
nation or breaches of personal privacy. For example, they may examine whether the
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researchers have implemented all necessary safeguards to prevent algorithmic bias and comply
with data security standards.
Examining the methodological soundness of health-related big data studies will likely
require the adoption of different assessment criteria compared to traditional biomedical
research. For example, it may require a rethinking of what counts as “public” data and what
counts as “harm” in data-driven research. In addition, big data research is usually not based on
the formulation and testing of specific research hypotheses, but on the identification of pat-
terns from large volumes of data. This hypothesis-free nature of (some) big data research
makes it harder to apply conventional epistemological mechanisms for scientific demarcation
and quality control like falsifiability and refutability [62]. This poses for ERCs the problem of
clearly demarcating the explanatory power of big data driven research. Researchers have ques-
tioned that big data analytics might speak for themselves [63] independent of explanatory
hypotheses and refuted the idea that they can be used for biomedical purposes in absence of
robust and causally explanatory scientific models or theories [64, 65].
Ethical challenges also constitute an important area of consideration for ERCs. Data break-
down by class of ethical consideration reveals that the current ethical debate is being largely
monopolized by issues of privacy and data protection (Fig 3). It was already pointed out, that
the ethics of big data should not be reduced to a privacy challenge but it encompasses a num-
ber of positive ethical goals [66]. Several ethical issues for which Mittelstad and Floridi [22]
demanded increased ethical attention still appear largely underexplored. For example, our
analysis reveals that issues of data ownership, group-level ethical harms, and the distinction
between academic and commercial uses of big data, do not appear as ethical priorities. Fur-
thermore, we observed that issues of fairness and the risk of discrimination compose a rela-
tively small portion of the current ethical spectrum even though the misuse of big data has
demonstrably resulted in various forms of ethnic, gender and class discrimination [67]. While
group-level harms are usually considered outside the purview of ERCs, the dangers of ignoring
this type of risk require careful assessment [68]. Issues of trust, transparency, accountability,
dignity compose an even smaller fraction of the current ethical landscape. We suggest that the
ethical review of health-related big data research should explore a broader spectrum of ethical
issues. In particular, it should scrutinize more carefully (i) whether and how each project
attempts to address the social benefits, if any, of research; (ii) how data subjects involved in the
study can exercise control over their data (data control problem); (iii) which measures of
accountability are being employed by the researchers, (iv) whether the collected data can be
reused for secondary, including malevolent, purposes (dual use problem) and what measures
are implemented to prevent that.
These technical, methodological and ethical challenges should not be seen as sealed rooms.
Thematic analysis reveals an intimate interconnection between the three thematic families.
For example, the technical problem of data security appears strictly connected to the ethical
notion of privacy and the regulatory principle of data protection. Similarly, methodological
errors like dataset bias might have detrimental ethical consequences such as racial and gender
discrimination. This intimate link between technical and ethical issues highlights the impor-
tance of cooperative approaches to study design in big data research through strategies like
ethical design of data-collecting technologies, proactive ethical assessment of big data studies
and ethical requirement analyses for data-sharing platforms, data storage sites and other digital
infrastructures. ERCs should be sensitized to this interconnection and examine how weak-
nesses in one domain affect other domains of evaluation. Similarly, the interdependence of
epistemological and ethical issues, which was already highlighted by Mittelstad and Floridi
[22], requires careful consideration by ERCs to prevent that inaccurate study designs or data
curation practices result in unintended harms to individuals or groups.
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Overall, these findings have three main and direct implications for ERCs. First, the signifi-
cance and complexity of technical and methodological challenges suggests that members of
ERCs should need to acquire stronger technical and methodological expertise to adequately
review and evaluate health-related big data studies. This might require specific educational
courses or other training activities aimed at strengthening ERC-members’ ability to identify
technical/methodological problems or inaccuracies, especially those that can result in harms to
data subjects or society like data security breaches, database corruption and biased algorithm
training. Specialized training modules in data science, bioinformatics and cybersecurity might
serve this purpose. In parallel, as emerging from the normative suggestions, ERCs need to con-
sider including experts from the afore listed disciplines within the review board. Since health-
related big data is here to stay, new expert profiles are needed during the review process. Data
scientists, security experts, bioinformaticians should complement the expertise of clinicians,
ethicists and other traditional ERC members. ERC members will need to be equipped with the
necessary tools to inspect how the data will be collected, in conformity with which security
standards they will be stored and shared, what classification systems will be employed, how
uncertainty will be quantified, what cluster models will be adopted during exploratory data
mining etc.
In spite of these important challenges, ERCs might still be faced with uncertainty when
reviewing health-related big data studies. Review results indicate that only a tiny fraction of
studies (13%) provided specific normative recommendations for ERCs. These are suggestions
or proposals for ERCs as to the best course of action. Further thematic analysis reveals a gen-
eral disagreement and a lack of consensus on what codes of conduct should be prioritized, with
some authors [25] favouring the simplification of the ethics review process and others [69]
requiring more stringent scrutiny. Nonetheless, five recurring themes could be identified: (i)
preventing the dangers of downstream data linkage and inadvertent individual identification;
(ii) expanding the purview and involvement of ERCs; (iii) developing a clearer understanding
of the risks and benefits of health-related big data research, (iv) harmonizing ethical standards
for big data research and (v) rethinking the composition of ERCs. The extremely small fraction
of studies providing normative recommendations informed by empirical research (i.e. based on
studies involving direct observation or experience such as survey questionnaires or focus
groups), further underscores how these recommendations are mostly based on individual view-
points rather than on solid consensus within the research community.
In the debate on what ERCs should do in relation to health-related big data, the opinion of
ERC members is missing. Future empirical research is highly required to explore the needs,
views and attitudes of ERC members about health-related big data. Empirical research in this
domain could methodologically build upon previous studies involving ethics advisors working
in big-data-related areas of research such as genomics governance [70]. Combining empirical
and normative ethical research in the health-related big data domain would not only benefit
the understanding of the current problems that ERCs are facing when reviewing health-related
big data studies, but also favour the development of empirically-informed research ethics
guidelines [71], hence resulting in better ethical oversight and governance of the health-related
big data phenomenon.
Finally, it is legitimate to raise the question of whether ERCs should be the only governance
body responsible for the evaluation of biomedical big data research. Given their traditional
mandate, which is deeply rooted in the pre-digital era of biomedical research, it might be rea-
sonably argued that ERCs are ill-suited to exercise exclusive ethical oversight on health-related
big data research. Research regulators should consider whether complementary governance
mechanisms such as data boards, data security committees or allied bodies are necessary to
expand the bandwidth and sensitivity of ethical oversight.
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